LATEST NEWS
LATEST EVENTS
30 SEPTEMBER 2008
Exco InTouch’s Electronic Patient Diary Selected by Synairgen to Capture ePRO Data in IFN-beta Asthma Trial
(30 September, 2008) Exco
InTouch, the leading mobile messaging provider for the pharmaceutical industry,
announces that its electronic patient reported outcomes (ePRO) solutions have
been selected by Synairgen, a drug discovery company focused on asthma and chronic
obstructive pulmonary disease (COPD). Exco InTouch’s short message service
(SMS) ePRO offerings will enable Synairgen to collect patient data in its
second clinical study of inhaled interferon beta (IFN-beta) for asthma treatment.
This Phase 1 study from
Synairgen is designed to establish the safety of inhaled IFN-beta at four
different dose levels over a 14 day period in asthmatic volunteers. Exco
InTouch’s innovative text messaging ePRO system will enable Synairgen to
collect accurate PRO data which might be crucial in gauging the efficacy in
future studies.
Using secure mobile online
access, this technology will allow patients to complete diary questionnaires at
pre-specified times via a series of text messages. Secure text messages will
enable Synairgen’s patients to easily record and transmit data concerning their
asthma using their own mobile phone, facilitating diary data collection which
is then relayed back to the clinical sites for further analyses.
“Symptom diary cards are
notoriously unreliable; we are attracted to this simple method for collecting
asthma symptom scores on a daily basis” said
About Exco InTouch’s ePRO
Solutions
For more complex data
collection, a java application which runs on the patient’s own mobile phone can
be used in mobile data capture, dose titration and disease exacerbation
monitoring. Simple and easy to deploy, Exco InTouch’s software can be used for
daily questionnaires in conjunction with the REACT™ compliance platform to
deliver high quality data within appropriate timeframes.
For further information on
the Exco InTouch ePRO portfolio, please call +44 1279 408 210 or +1 949 725
2946 or visit www.excointouch.com
-ENDS-
For further press
information please contact: